OPKO Health Total Long Term Liabilities 2010-2024 | OPK

OPKO Health total long term liabilities from 2010 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.
OPKO Health Annual Total Long Term Liabilities
(Millions of US $)
2023 $422
2022 $392
2021 $385
2020 $426
2019 $445
2018 $371
2017 $434
2016 $412
2015 $567
2014 $349
2013 $427
2012 $59
2011 $50
2010 $27
2009 $43
OPKO Health Quarterly Total Long Term Liabilities
(Millions of US $)
2024-06-30 $365
2024-03-31 $517
2023-12-31 $422
2023-09-30 $412
2023-06-30 $397
2023-03-31 $395
2022-12-31 $392
2022-09-30 $328
2022-06-30 $435
2022-03-31 $383
2021-12-31 $385
2021-09-30 $369
2021-06-30 $375
2021-03-31 $419
2020-12-31 $426
2020-09-30 $412
2020-06-30 $456
2020-03-31 $439
2019-12-31 $445
2019-09-30 $457
2019-06-30 $464
2019-03-31 $417
2018-12-31 $371
2018-09-30 $375
2018-06-30 $414
2018-03-31 $438
2017-12-31 $434
2017-09-30 $374
2017-06-30 $379
2017-03-31 $388
2016-12-31 $412
2016-09-30 $440
2016-06-30 $477
2016-03-31 $528
2015-12-31 $567
2015-09-30 $689
2015-06-30 $518
2015-03-31 $517
2014-12-31 $349
2014-09-30 $331
2014-06-30 $335
2014-03-31 $440
2013-12-31 $427
2013-09-30 $444
2013-06-30 $269
2013-03-31 $276
2012-12-31 $59
2012-09-30 $57
2012-06-30 $47
2012-03-31 $47
2011-12-31 $50
2011-09-30 $28
2011-06-30 $28
2011-03-31 $28
2010-12-31 $27
2010-09-30 $27
2010-06-30 $1
2010-03-31 $1
2009-12-31 $43
2009-09-30 $15
2009-06-30 $14
2009-03-31 $14
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.130B $0.864B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $233.063B 27.94
Intuitive Surgical (ISRG) United States $171.313B 97.00
Alcon (ALC) Switzerland $47.672B 33.56
IQVIA Holdings (IQV) United States $44.239B 25.07
IDEXX Laboratories (IDXX) United States $42.083B 50.62
Edwards Lifesciences (EW) United States $40.680B 26.07
DexCom (DXCM) United States $27.834B 39.69
STERIS (STE) Ireland $23.508B 27.43
SONOVA HOLDING (SONVY) Switzerland $20.781B 0.00
Waters (WAT) United States $19.789B 29.50
Hologic (HOLX) United States $18.981B 20.64
Sysmex ADR (SSMXY) Japan $12.317B 38.62
Fresenius Medical Care AG KGaA (FMS) Germany $12.224B 13.70
Teleflex (TFX) United States $11.380B 17.69
Globus Medical (GMED) United States $9.423B 26.36
Penumbra (PEN) United States $7.597B 78.86
Glaukos (GKOS) United States $6.721B 0.00
Masimo (MASI) United States $6.081B 32.57
TransMedics (TMDX) United States $5.203B 222.80
PROCEPT BioRobotics (PRCT) United States $4.309B 0.00
Integer Holdings (ITGR) United States $4.304B 25.17
Tandem Diabetes Care (TNDM) United States $2.791B 0.00
LivaNova (LIVN) United Kingdom $2.773B 16.26
Veracyte (VCYT) United States $2.593B 160.76
Inari Medical (NARI) United States $2.586B 0.00
Elekta AB (EKTAY) Sweden $2.562B 20.88
Nihon Kohden (NHNKY) Japan $2.508B 15.61
RxSight (RXST) United States $2.003B 0.00
Integra LifeSciences Holdings (IART) United States $1.360B 6.19
Pulse Biosciences (PLSE) United States $1.163B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.112B 19.84
Artivion (AORT) United States $1.046B 96.04
Alphatec Holdings (ATEC) United States $0.864B 0.00
OrthoPediatrics (KIDS) United States $0.728B 0.00
Mesa Laboratories (MLAB) United States $0.682B 17.23
SiBone (SIBN) United States $0.654B 0.00
AxoGen (AXGN) United States $0.638B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.616B 0.00
IRadimed (IRMD) United States $0.614B 33.19
Paragon 28 (FNA) United States $0.581B 0.00
Pacific Biosciences Of California (PACB) United States $0.526B 0.00
Treace Medical Concepts (TMCI) United States $0.341B 0.00
Sight Sciences (SGHT) United States $0.330B 0.00
Tactile Systems Technology (TCMD) United States $0.327B 9.98
ClearPoint Neuro (CLPT) United States $0.322B 0.00
AngioDynamics (ANGO) United States $0.306B 0.00
Inogen (INGN) United States $0.253B 0.00
Delcath Systems (DCTH) United States $0.251B 0.00
Nevro (NVRO) United States $0.217B 0.00
NeuroPace (NPCE) United States $0.199B 0.00
Accuray (ARAY) United States $0.190B 0.00
CVRx (CVRX) United States $0.189B 0.00
Atossa Genetics (ATOS) United States $0.179B 0.00
Semler Scientific (SMLR) United States $0.173B 12.15
Alpha Tau Medical (DRTS) Israel $0.162B 0.00
Spectral Diagnostics (EDTXF) Canada $0.135B 0.00
908 Devices (MASS) United States $0.128B 0.00
KORU Medical Systems (KRMD) United States $0.122B 0.00
EDAP TMS S.A (EDAP) France $0.114B 0.00
Monogram Orthopaedics (MGRM) United States $0.103B 0.00
Sensus Healthcare (SRTS) United States $0.099B 14.81
Hyperfine (HYPR) United States $0.070B 0.00
EnVVeno Medical (NVNO) United States $0.068B 0.00
InspireMD (NSPR) Israel $0.066B 0.00
WORK Medical Technology Group (WOK) China $0.063B 0.00
Covalon Technologies (CVALF) Canada $0.062B 0.00
Envoy Medical (COCH) United States $0.061B 0.00
LENSAR (LNSR) United States $0.049B 0.00
Lucid Diagnostics (LUCD) United States $0.045B 0.00
T2 Biosystems (TTOO) United States $0.038B 0.00
Rapid Micro Biosystems (RPID) United States $0.036B 0.00
Precision Optics (POCI) United States $0.035B 0.00
Accelerate Diagnostics (AXDX) United States $0.035B 0.00
Vicarious Surgical (RBOT) United States $0.034B 0.00
Adagio Medical Holdings (ADGM) United States $0.032B 0.00
Neuronetics (STIM) United States $0.029B 0.00
Lifeward (LFWD) United States $0.028B 0.00
DarioHealth (DRIO) United States $0.027B 0.00
Ekso Bionics Holdings (EKSO) United States $0.022B 0.00
Pixie Dust Technologies (PXDT) Japan $0.022B 0.00
Spectral AI (MDAI) United States $0.021B 0.00
PAVmed (PAVM) United States $0.017B 0.00
NexGel (NXGL) United States $0.016B 0.00
Autonomix Medical (AMIX) United States $0.016B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.016B 0.00
Microbot Medical (MBOT) United States $0.015B 0.00
Aspira Women's Health (AWH) United States $0.013B 0.00
QT Imaging Holdings (QTI) United States $0.013B 0.00
Check-Cap (CHEK) Israel $0.010B 0.00
ReShape Lifesciences (RSLS) United States $0.005B 0.00
ENDRA Life Sciences (NDRA) United States $0.004B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.003B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.003B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Nuwellis (NUWE) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00